Company Filing History:
Years Active: 2005-2015
Title: Yaron Hakak: Innovator in Metabolic Research
Introduction
Yaron Hakak is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of metabolic research, particularly in the treatment of insulin resistance and atherosclerosis. With a total of 4 patents to his name, Hakak's work is paving the way for new therapeutic approaches.
Latest Patents
Hakak's latest patents include a method for screening compounds useful in the treatment of insulin resistance, impaired glucose tolerance, or diabetes. This invention involves identifying a metabolic stabilizing compound by contacting a candidate compound with GPR43 and determining whether GPR43 functionality is modulated. The invention also encompasses methods for identifying compounds that reduce atherogenesis, utilizing G protein-coupled receptors (GPCR) to assess whether a candidate compound is a modulator of atherogenesis. These agonists are valuable as therapeutic agents for preventing or treating atherosclerotic diseases, including coronary artery disease and myocardial infarction.
Career Highlights
Throughout his career, Yaron Hakak has worked with notable companies such as Arena Pharmaceuticals, Inc. His innovative research has contributed to advancements in understanding metabolic disorders and cardiovascular health.
Collaborations
Hakak has collaborated with esteemed colleagues, including David J Unett and Ruoping Chen, further enhancing the impact of his research in the scientific community.
Conclusion
Yaron Hakak's contributions to metabolic research and his innovative patents highlight his role as a leading inventor in the field. His work continues to inspire advancements in the treatment of critical health conditions.